dc.contributor.author |
Golubev A. |
|
dc.contributor.author |
Negroni L. |
|
dc.contributor.author |
Krasnovid F. |
|
dc.contributor.author |
Validov S. |
|
dc.contributor.author |
Yusupova G. |
|
dc.contributor.author |
Yusupov M. |
|
dc.contributor.author |
Usachev K. |
|
dc.date.accessioned |
2021-02-25T20:54:10Z |
|
dc.date.available |
2021-02-25T20:54:10Z |
|
dc.date.issued |
2020 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/162594 |
|
dc.description.abstract |
© 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. Antibiotic-resistant Staphylococcus aureus is becoming a major burden on health care systems in many countries, necessitating the identification of new targets for antibiotic development. Elongation Factor P (EF-P) is a highly conserved elongation protein factor that plays an important role in protein synthesis and bacteria virulence. EF-P undergoes unique posttranslational modifications in a stepwise manner to function correctly, but experimental information on EF-P posttranslational modifications is currently lacking for S. aureus. Here, we expressed EF-P in S. aureus to analyze its posttranslational modifications by mass spectrometry and report experimental proof of 5-aminopentanol modification of S. aureus EF-P. |
|
dc.subject |
EF-P |
|
dc.subject |
posttranslational modifications |
|
dc.subject |
ribosome |
|
dc.subject |
stalling |
|
dc.subject |
Staphylococcus aureus |
|
dc.title |
Posttranslational modification of Elongation Factor P from Staphylococcus aureus |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
7 |
|
dc.relation.ispartofseries-volume |
10 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
1342 |
|
dc.source.id |
SCOPUS-2020-10-7-SID85087186292 |
|